COVID-19 Related Information
CIUSSS policies regarding access to the Douglas
Access points |
||
| Perry Pavilion | Access for all | |
| Bond Pavilion | Access for all | |
| Reed Pavilion | Access limited to visitors and employees of the ER, UIB, Reed 2, and intensive care. May be used to access Porteous. |
*** Special notices ***
- Use of unauthorized access points is prohibited and is being increasingly monitored by CIUSSS Security.
- With the pandemic and distancing measures, the cafeteria has reduced seating and employees are encouraged to bring their own meals to avoid a high volume of people at the same time in the cafeteria.
(last update January 28, 2021)
Required PPE |
|
| Please note that used masks must be placed in garbages and not left on the Douglas grounds, in the tunnels, stairwells, etc. |
(last update October 15, 2020)
Voluntary testing services on the Douglas grounds
A voluntary testing service available on-site at the Douglas (follow bright yellow signs on the east side of the Douglas Hall building). Tests can be obtained for free, without a referral, on a first-come, first-serve basis.
Please consult
- Montreal declared a COVID-19 red zone
- Guidelines in the advent an individual tests positive for COVID-19
- The Federal Government has put in place a Research Continuity Emergency Fund (CRCEF) to support research institutions cope with extra expenses due to the COVID-19 pandemic. See how this applies to the Douglas Research Centre here.
- Helpful information and "How to" videos from McGill University
- Protocols and specific guidelines designed to address safety concerns among the COVID-19 pandemic
- Guidelines for resumption of research involving human subjects
- Guidelines for resumption of research activities at the Douglas
Forms
- Daily Log - Example Form
- Phase 4 is tentatively scheduled to start on July 15.
- Acknowledgement of research resumption plan for individuals engaging in on-site research activities.
- Approved Addendum for research projects involving human subjects
- Modifications to research protocols in order to adapt to the constraints and risks associated with COVID-19
